The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Berinert 1500 IU Powder and solvent for solution for injection



CSL Behring GmbHPA0800/013/002

Main Information

Trade NameBerinert 1500 IU Powder and solvent for solution for injection
Active SubstancesC1 Esterase Inhibitor (Human)
Dosage FormPowder and solvent for solution for injection
Licence HolderCSL Behring GmbH
Licence NumberPA0800/013/002

Group Information

ATC CodeB06AC01 c1-inhibitor, plasma derived

Status

License statusAuthorised
Licence Issued27/08/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back